NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Tuesday, October 30th. Shareholders of record on Friday, December 14th will be paid a dividend of $0.335 per share on Wednesday, January 2nd. This represents a $1.34 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date is Thursday, December 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) announced its earnings results on Wednesday, February, 20th. The specialty chemicals company reported $1.53 EPS for the quarter, topping the Zacks' consensus estimate of $1.46 by $0.07. The specialty chemicals company earned $921.70 million during the quarter, compared to analyst estimates of $894.45 million. Albemarle had a return on equity of 15.39% and a net margin of 10.44%. Albemarle's revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $1.34 earnings per share. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY19 earnings guidance on Wednesday, February, 20th. The company provided EPS guidance of $6.10-6.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.14. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.64 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS.

17 analysts have issued 12-month target prices for Albemarle's shares. Their forecasts range from $59.00 to $150.00. On average, they anticipate Albemarle's share price to reach $107.4131 in the next twelve months. This suggests a possible upside of 20.3% from the stock's current price. View Analyst Price Targets for Albemarle.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

Media stories about ALB stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Albemarle earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave press coverage about the specialty chemicals company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near term.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), PolyOne (POL), Rogers (ROG), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), Cereplast (CERPQ), A Schulman (SHLM) and ForceField Energy (FNRG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), NVIDIA (NVDA), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA), General Electric (GE), Intel (INTC), Netflix (NFLX) and AutoCanada (ACQ).

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.01%), Jennison Associates LLC (6.55%), Bank of New York Mellon Corp (3.02%), Baillie Gifford & Co. (2.48%), Bank of America Corp DE (1.78%) and Iridian Asset Management LLC CT (1.63%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Jennison Associates LLC, Carmignac Gestion, Mirae Asset Global Investments Co. Ltd., Iridian Asset Management LLC CT, QCI Asset Management Inc. NY, Anchor Bolt Capital LP and United Services Automobile Association. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was acquired by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., State of Tennessee Treasury Department, Principal Financial Group Inc., Robecosam AG, CIBC Private Wealth Group LLC, Dimensional Fund Advisors LP, Handelsbanken Fonder AB and State of New Jersey Common Pension Fund D. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $89.26.

Albemarle has a market capitalization of $9.48 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]